Sunday - January 12, 2025
Cancer Immunology, Immunotherapy Issues Research Articles in January 2024 Edition
January 15, 2024
BASEL, Switzerland, Jan. 15 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its January 2024 edition (Vol. 73, Issue 1):

* Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors

* Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell l . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products